tiprankstipranks
Quoin Pharmaceuticals (QNRX)
NASDAQ:QNRX
US Market
QNRX
Quoin Pharmaceuticals
RESEARCH TOOLSreports
Want to see QNRX full AI Analyst Report?

Quoin Pharmaceuticals (QNRX) Income Statement

378 Followers

Quoin Pharmaceuticals Income Statement

Last quarter (Q1 2026), Quoin Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Quoin Pharmaceuticals's net income was $-4.98M. See Quoin Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 16.29M$ 9.53M$ 9.38M$ 9.26M$ 6.06M
Depreciation and Amortization
$ 100.00K$ 100.00K$ 103.71K$ 104.04K$ 104.04K
EBITDA
$ -16.19M$ -9.43M$ -9.27M$ -8.56M$ -20.27M
Operating Income
$ -16.29M$ -9.53M$ -9.38M$ -9.26M$ -6.06M
Other Income/Expenses
$ 486.06K$ 565.99K$ 691.93K$ -123.79K$ -15.40M
Pretax Income
$ -15.80M$ -8.96M$ -8.69M$ -9.38M$ -21.46M
Net Income
$ -15.80M$ -8.96M$ -8.69M$ -9.38M$ -21.46M
Per Share Metrics
Basic EPS
$ -10.63$ -66.85$ -337.47$ -22.97$ -28.54K
Diluted EPS
$ -10.63$ -66.85$ -337.47$ -22.97$ -28.54K
Weighted Average Shares Outstanding
 1.50M 133.96K 25.74K 403.88K 1.60K
Weighted Average Shares Outstanding (Diluted)
 1.50M 133.96K 25.74K 403.88K 1.60K
Currency in USD

Quoin Pharmaceuticals Earnings and Revenue History